Company: GCL
Filing Date: 2025-07-31
Form Type: 20-F
Source: 0001213900-25-069672
Chunk: 15

Company: GCL Global Holdings Ltd
Filing Date: 2025-07-31
Form: 20-F
Item: Item 3
Chunk 15
---
                            

  difficulties                                                                              

  difficulties                                                                                 

  failure                                                                  

  exclusivity                                                                                

  failure                                                                                          

  expanding                                                                                        

  failure                                                                                     

  risks                                                                                     
  that regulatory bodies do not approve our acquisitions or business combinations or delay  
  such approvals or other adverse reactions from regulators, which may result in blockade,  
  delay or restructuring of such transactions;                                              
 ────────────────────────────────────────────────────────────────────────────────────────────

  regulatory                                                                                 
  changes that require adjustments to our business or shareholding or rights in relation to  
  subsidiaries or joint ventures;                                                            
 ─────────────────────────────────────────────────────────────────────────────────────────────

  any                                                                                           
  significant use of cash or incurrence of debt to finance the transactions may restrict our    
  business and any issuance of equity and/or convertible note to finance or otherwise complete  
  the transactions may result in dilution to our shareholders;                                  
 ────────────────────────────────────────────────────────────────────────────────────────────────

  adverse                                                             

  distraction                                                                                 

If we fail to address the risks or other problems encountered in connection
with past or future transactions such as the foregoing, or if we fail to successfully integrate or manage such transactions, our business,
financial condition, results of operations and prospects could be materially and adversely affected.

We plan to raise additional funds through
sale of equity or convertible debt securities in order to fuel business growth.

To fuel the growth of our
business, we plan to raise financing through sale of equity or convertible debt securities in the near future. However, there is no assurance
that such financing will be available to us when needed, or if available, on terms that are favorable to us. Should the financing we require
be unavailable to us, or on terms unacceptable to us when we require it, we may have to delay, curtail or alter our strategic acquisition
or business plans, and as a result, our business, operating results, financial condition, and prospects could be materially adversely
affected.

The terms of any securities
issued by us in future capital transactions may be more favorable to new investors, and may include preferences, superior voting rights
and the issuance of warrants or other derivative securities, which may have a further dilutive effect on the holders of any of our securities
then outstanding. In addition, we may incur substantial costs in pursuing future capital financing, including investment banking fees,
legal fees, accounting fees, securities law compliance fees, printing and distribution expenses and other costs.